Emirates targets high-value healthcare travel
The Emirates medical tourism push is anchored in the airline’s global network of close to 140 destinations. It also draws on Dubai’s status as a healthcare hub. According to Emirates’ ATM 2026 announcements, the partnership with the Medical Tourism Association (MTA) aims to build a structured approach to medical, wellness and longevity travel as a strategic customer segment for the airline. The MoU was signed in Dubai on 17 September 2026, on the sidelines of ATM 2026.
Emirates is partnering with MTA as the preferred airline for international medical and wellness travellers. The alliance combines its global network with Dubai’s healthcare infrastructure to attract affluent, treatment-focused visitors. As part of the agreement, the two organisations will identify key markets and medical travel corridors, particularly across Africa, Asia and the Middle East. They will also design tailored travel solutions and customer experiences for patients, referring physicians, insurers and employers.
This creates a demand-led strategy that links origin markets, specialist providers and airline capacity in a single coordinated offer. MTA brings significant distribution scale to the alliance. Its global network reaches more than 500,000 healthcare providers, employers, insurers and industry leaders, as well as millions of prospective medical and wellness travellers each year, according to association data.
The Better by MTA platform and what it adds
The partnership will use MTA’s Better by MTA platform. This platform integrates care coordination, travel and cross-border payments powered by Mastercard, helping travellers identify accredited providers, coordinate treatment and pay securely. For Emirates, this plugs the airline directly into an established medical travel ecosystem rather than forcing it to build one from scratch.
Adnan Kazim, Emirates’ Deputy President and Chief Commercial Officer, has framed the move as a response to robust demand. He stated that healthcare is among the most important reasons people travel internationally and is growing significantly. His comments signal a shift in network strategy towards segments that offer both premium yields and resilience to discretionary travel cycles.
What does the deal mean for investors?
The partnership is designed not only to drive traffic, but also to raise international standards across the medical travel sector. Emirates and MTA will work with providers accredited by Global Healthcare Accreditation (GHA) on thought leadership, industry engagement and shared market intelligence. The agreement also supports Emirates’ ambition to become the world’s first GHA-accredited airline. That quality and compliance focus aligns with the needs of insurers and large employers managing cross-border healthcare benefits.
For investors, this quality signal matters. It can underpin repeat business and institutional partnerships rather than one-off bookings. The alliance integrates Emirates’ network to and from Dubai into MTA’s ecosystem of more than 500,000 providers, insurers and employers in over 100 countries. This gives the airline access to a broad funnel of pre-qualified medical travellers. According to MTA communications, the platform is designed so that demand flows from a global airline to accredited providers, rewarding institutions that meet higher standards.
This is where ancillary revenue opportunities emerge, from bundled travel-treatment packages to loyalty-linked wellness offerings and corporate health travel programmes. For Dubai, the strategy reinforces the emirate’s ambition to consolidate itself as a global healthcare and wellness hub. Regional market estimates suggest the UAE medical tourism market is approaching US$865.8 million in 2025, with strong double-digit growth into the next decade, according to recent industry analysis.
Africa, Asia and the Middle East drive the opportunity
The new partnership positions Emirates to capture a larger share of that spend. It also channels demand towards Dubai’s clinics and hospitals, supporting wider economic diversification goals. The agreement’s focus on Africa, Asia and the Middle East aligns with the carrier’s existing strengths in long-haul connectivity. It links emerging middle classes with specialist care in markets that remain fragmented and often opaque.
Emirates is quietly turning medical tourism from a niche into a core premium segment, with Dubai as its natural hub. As product propositions for these travellers mature, from tailored booking flows to onboard services geared to post-treatment needs, the airline could build defensible advantages in a market that conventional carriers have largely ignored. The move also sits alongside the wider Gulf aviation sector’s push into premium travel innovations seen across ATM 2026.
Investors and policymakers should now watch how quickly Emirates converts the MoU into accredited routes, branded products and measurable flows of medical travellers, and whether Global Healthcare Accreditation for an airline becomes a new benchmark for premium, health-linked travel.
Quick answers
Emirates signed a strategic MoU with the Medical Tourism Association on 17 September 2026 in Dubai, making it the preferred airline for international medical, wellness and longevity travellers and giving it access to MTA’s network of more than 500,000 healthcare providers, insurers and employers in over 100 countries.
Industry analysis estimates the UAE medical tourism market is approaching US$865.8 million in 2025, with strong double-digit growth projected into the next decade.
Global Healthcare Accreditation (GHA) is the sector’s specialised accreditation body for medical travel quality and compliance. Emirates aims to become the world’s first GHA-accredited airline, a status that can secure repeat business from insurers and large employers managing cross-border healthcare benefits.
